David F Kallmes
Overview
Explore the profile of David F Kallmes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
584
Citations
10083
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radley N, Soh I, Saad A, Wickramarachchi M, Dawson A, Hin J, et al.
J Stroke Cerebrovasc Dis
. 2025 Mar;
:108291.
PMID: 40089217
Background: Stroke is a major cause of mortality and permanent disability worldwide. Precise prediction of post-stroke mortality is essential for guiding treatment decisions and rehabilitation planning. The ability of Machine...
2.
Evaluation of FeMnN alloy bioresorbable flow diverters in the rabbit elastase induced aneurysm model
Oliver A, Bilgin C, Cortese J, Bayraktar E, Dai D, Ding Y, et al.
Front Bioeng Biotechnol
. 2025 Mar;
13:1522696.
PMID: 40070550
Introduction: Flow diverters are specialized stents used to treat intracranial aneurysms. Bioresorbable flow diverters (BRFDs) have been proposed as the next-generation of flow diverter technology. BRFDs aim to occlude and...
3.
Cortese J, Ghozy S, Valizadeh P, Hasanzadeh A, Amoukhteh M, Jannatdoust P, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
46(3):510-516.
PMID: 40016131
Background: The Pipeline Vantage Flow diverter (Vantage) is the latest generation of Pipeline flow diverters introducing Cobalt-chronium drawn-filled tubing and 48 to 68 wires. Purpose: We report the initial safety...
4.
Kendall N, Pennington Z, Hamouda A, Cwajna M, Ghozy S, Kallmes D, et al.
J Clin Neurosci
. 2025 Feb;
135:111148.
PMID: 40010172
Introduction: ClinicalTrials.gov is an online database that was launched in 2000 in order to help increase transparency around clinical trials. The FDA's Food and Drug Administration Amendments Act of 2007...
5.
Thirupathi K, Ghozy S, Reda A, Ranatunga W, Ruben M, Armin Z, et al.
Brain Sci
. 2025 Feb;
15(2).
PMID: 40002490
Variability in recanalization success during endovascular treatment for acute ischemic stroke (AIS) has led to increased interests in thrombus composition and associated cellular materials. While evidence suggests that bacteria may...
6.
Ghozy S, Jazayeri S, Hasanzadeh A, Ognard J, Kobeissi H, Ahmadzade A, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
PMID: 39984186
Background: Cerebral aneurysm recurrence serves as a significant endpoint for assessing the efficacy of various endovascular treatment strategies. The impact of smoking on outcomes such as aneurysm occlusion, recurrence, and...
7.
Ueki Y, Naylor R, Ghozy S, Thirupathi K, Rinaldo L, Kallmes D, et al.
J Cereb Blood Flow Metab
. 2025 Feb;
:271678X251319913.
PMID: 39948029
Brain arteriovenous malformations (bAVMs) are a notable cause of intracranial hemorrhage, strongly associated with severe morbidity and mortality. Contemporary treatment options include surgery, stereotactic radiosurgery, and endovascular embolization, each of...
8.
Jazayeri S, Zamarud A, Derhab M, Ghozy S, Mirbeyk M, Heit J, et al.
J Neurointerv Surg
. 2025 Feb;
PMID: 39947893
Background: The hypoperfusion intensity ratio (HIR) has emerged as a vital measure of tissue-level collateral blood flow, helping to identify patients who are likely to benefit from mechanical thrombectomy (MT)....
9.
Bilgin C, Gupta R, Orscelik A, Hassankhani A, Senol Y, Kobeissi H, et al.
Neuroradiol J
. 2025 Feb;
:19714009251317499.
PMID: 39891596
Background: Carotid artery tortuosity (CAT) may complicate mechanical thrombectomy (MT), potentially causing delays or preventing recanalization. However, the relationship between CAT and MT outcomes remains largely unexplored. This systematic review...
10.
Kendall N, Hamouda A, Cwajna M, Gajjar A, Derhab M, Ghozy S, et al.
J Clin Neurosci
. 2025 Jan;
134:111090.
PMID: 39879723
Background: For unruptured intracranial aneurysms (UIAs), conservative management is often possible. However, when direct treatment is warranted, endovascular treatments (EVTs) provide an effective minimally invasive approach. These procedures still necessitate...